246 related articles for article (PubMed ID: 9060656)
1. Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains.
Jones TR; Sun L
J Virol; 1997 Apr; 71(4):2970-9. PubMed ID: 9060656
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.
Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336
[TBL] [Abstract][Full Text] [Related]
3. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains.
Jones TR; Wiertz EJ; Sun L; Fish KN; Nelson JA; Ploegh HL
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11327-33. PubMed ID: 8876135
[TBL] [Abstract][Full Text] [Related]
4. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11.
Schust DJ; Tortorella D; Seebach J; Phan C; Ploegh HL
J Exp Med; 1998 Aug; 188(3):497-503. PubMed ID: 9687527
[TBL] [Abstract][Full Text] [Related]
5. Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation.
Barel MT; Pizzato N; Le Bouteiller P; Wiertz EJ; Lenfant F
Int Immunol; 2006 Jan; 18(1):173-82. PubMed ID: 16361314
[TBL] [Abstract][Full Text] [Related]
6. Human cytomegalovirus US3 chimeras containing US2 cytosolic residues acquire major histocompatibility class I and II protein degradation properties.
Chevalier MS; Johnson DC
J Virol; 2003 Apr; 77(8):4731-8. PubMed ID: 12663780
[TBL] [Abstract][Full Text] [Related]
7. Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation.
Chevalier MS; Daniels GM; Johnson DC
J Virol; 2002 Aug; 76(16):8265-75. PubMed ID: 12134032
[TBL] [Abstract][Full Text] [Related]
8. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains.
Jones TR; Hanson LK; Sun L; Slater JS; Stenberg RM; Campbell AE
J Virol; 1995 Aug; 69(8):4830-41. PubMed ID: 7609050
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.
Johnson DC; Hegde NR
Curr Top Microbiol Immunol; 2002; 269():101-15. PubMed ID: 12224504
[TBL] [Abstract][Full Text] [Related]
10. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process.
Ahn K; Angulo A; Ghazal P; Peterson PA; Yang Y; Früh K
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10990-5. PubMed ID: 8855296
[TBL] [Abstract][Full Text] [Related]
11. Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation.
Barel MT; Ressing M; Pizzato N; van Leeuwen D; Le Bouteiller P; Lenfant F; Wiertz EJ
J Immunol; 2003 Dec; 171(12):6757-65. PubMed ID: 14662880
[TBL] [Abstract][Full Text] [Related]
12. TRAM1 participates in human cytomegalovirus US2- and US11-mediated dislocation of an endoplasmic reticulum membrane glycoprotein.
Oresic K; Ng CL; Tortorella D
J Biol Chem; 2009 Feb; 284(9):5905-14. PubMed ID: 19121997
[TBL] [Abstract][Full Text] [Related]
13. Membrane-specific, host-derived factors are required for US2- and US11-mediated degradation of major histocompatibility complex class I molecules.
Furman MH; Ploegh HL; Tortorella D
J Biol Chem; 2002 Feb; 277(5):3258-67. PubMed ID: 11717308
[TBL] [Abstract][Full Text] [Related]
14. Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells.
Rehm A; Engelsberg A; Tortorella D; Körner IJ; Lehmann I; Ploegh HL; Höpken UE
J Virol; 2002 May; 76(10):5043-50. PubMed ID: 11967320
[TBL] [Abstract][Full Text] [Related]
15. Human cytomegalovirus US3 modulates destruction of MHC class I molecules.
Noriega VM; Hesse J; Gardner TJ; Besold K; Plachter B; Tortorella D
Mol Immunol; 2012 Jun; 51(2):245-53. PubMed ID: 22497807
[TBL] [Abstract][Full Text] [Related]
16. Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11.
Pande NT; Powers C; Ahn K; Früh K
J Virol; 2005 May; 79(9):5786-98. PubMed ID: 15827193
[TBL] [Abstract][Full Text] [Related]
17. Identifying the ERAD ubiquitin E3 ligases for viral and cellular targeting of MHC class I.
van den Boomen DJ; Lehner PJ
Mol Immunol; 2015 Dec; 68(2 Pt A):106-11. PubMed ID: 26210183
[TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus-encoded immune modulators partner to downregulate major histocompatibility complex class I molecules.
Noriega VM; Tortorella D
J Virol; 2009 Feb; 83(3):1359-67. PubMed ID: 19004944
[TBL] [Abstract][Full Text] [Related]
19. The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US)2, US3, US6, and US11 gene products.
Park B; Oh H; Lee S; Song Y; Shin J; Sung YC; Hwang SY; Ahn K
J Immunol; 2002 Apr; 168(7):3464-9. PubMed ID: 11907106
[TBL] [Abstract][Full Text] [Related]
20. Human cytomegalovirus US2 causes similar effects on both major histocompatibility complex class I and II proteins in epithelial and glial cells.
Hegde NR; Johnson DC
J Virol; 2003 Sep; 77(17):9287-94. PubMed ID: 12915544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]